Discover
MIRA
MIRA Pharmaceuticals, Inc.
0.71
2 x 0.52
2 x 0.94
bid
ask
-
0.02
3.22%
2 @ 04:00 PM
0.72 +0.01 (1.15%)
| Ytd | -52.86% | |
| 1y | -47.27% |
0.70
day range
0.76
0.60
52 week range
2.45
| Open | 0.76 | Prev Close | 0.74 | Low | 0.70 | High | 0.76 | Mkt Cap | 29.91M |
| Vol | 105.73K | Avg Vol | 591.40K | EPS | -1.14 | P/E | N/A | Forward P/E | -2.14 |
| Beta | 1.48 | Short Ratio | 0.47 | Inst. Own | 5.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.78 | 200-d Avg | 1.05 | 1yr Est | 12.08 |
MIRA News
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Milestone Scientific (AMEX:MLSS) stock moved upwards by 11.8% to $0.44 during Monday's
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark
benzinga.com
Maxim Group Initiates Coverage On Mira Pharmaceuticals with Buy Rating, Announces Price Target of $3
Maxim Group analyst Jason McCarthy initiates coverage on Mira Pharmaceuticals (NASDAQ:MIRA) with
benzinga.com
MIRA Pharmaceuticals Submits Phase 2a Ketamir‑2 Protocol For CIPN To IRB, Incorporating FDA Feedback
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage